Search
for
Sort by
Research 18
- Polycystic ovary syndrome and estroprogestins
- Effects of two estroprogestins containing ethynilestradiol 30mug and drospirenone 3 mg and ethynilestradiol 30mug and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations
- Anti-androgens for the treatment of hirsutism
- Hormonal contraceptives: pharmacology tailored to women's health
- Cutaneous manifestations of polycystic ovary syndrome
- Polycystic ovary syndrome: A review for dermatologists
- Effects of an oral contraceptive containing chlormadinone acetate and ethinylestradiol on hair and skin quality in women wishing to use hormonal contraception
- Effects of Oral Contraceptives Containing Desogestrel and Drospirenone on Clinical, Hormonal, and Metabolic Parameters of the Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial
- Actualización del Síndrome de Ovario Poliquístico y su importancia en Dermatología
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Ethinylestradiol/Chlormadinone Acetate
- The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
- [Disorder of hair growth in hyperprolactinemia].
- A narrative review on cutaneous manifestations in polycystic ovary syndrome: pathophysiology, diagnosis, management, and psychosocial impact
- National consensus on the management of patients with hyperandrogenism (2016)
- PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment
- Long-term Prophylaxis with Androgens in the management of Hereditary Angioedema (HAE) in emerging countries
- A systematic review on Drug Re-profiling/Re-Purposing